PT100415A - Novas morfolinas de accao farmaceutica, e processo para a sua preparacao - Google Patents

Novas morfolinas de accao farmaceutica, e processo para a sua preparacao

Info

Publication number
PT100415A
PT100415A PT100415A PT10041592A PT100415A PT 100415 A PT100415 A PT 100415A PT 100415 A PT100415 A PT 100415A PT 10041592 A PT10041592 A PT 10041592A PT 100415 A PT100415 A PT 100415A
Authority
PT
Portugal
Prior art keywords
morpholins
preparation
new pharmaceutical
pharmaceutical acid
human
Prior art date
Application number
PT100415A
Other languages
English (en)
Other versions
PT100415B (pt
Inventor
James Leroy Kelley
Mariman Bomanshaw Meht Boswell
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PT100415A publication Critical patent/PT100415A/pt
Publication of PT100415B publication Critical patent/PT100415B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
PT100415A 1991-04-23 1992-04-22 Novas morfolinas de accao farmaceutica, e processo para a sua preparacao PT100415B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108629A GB9108629D0 (en) 1991-04-23 1991-04-23 Heterocyclic pharmaceutical compounds,preparation and use

Publications (2)

Publication Number Publication Date
PT100415A true PT100415A (pt) 1993-06-30
PT100415B PT100415B (pt) 1999-08-31

Family

ID=10693740

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100415A PT100415B (pt) 1991-04-23 1992-04-22 Novas morfolinas de accao farmaceutica, e processo para a sua preparacao

Country Status (17)

Country Link
US (2) US5648347A (pt)
EP (1) EP0583271B1 (pt)
JP (1) JP3130040B2 (pt)
AT (1) ATE173252T1 (pt)
AU (1) AU668863B2 (pt)
CA (1) CA2108967C (pt)
DE (1) DE69227583T2 (pt)
DK (1) DK0583271T3 (pt)
ES (1) ES2124256T3 (pt)
FI (1) FI934680A7 (pt)
GB (1) GB9108629D0 (pt)
HU (1) HU219458B (pt)
IE (1) IE921260A1 (pt)
NZ (1) NZ242421A (pt)
PT (1) PT100415B (pt)
WO (1) WO1992018489A1 (pt)
ZA (1) ZA922910B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
US7098206B2 (en) * 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
CA2318268A1 (en) 1998-01-21 1999-07-29 Glaxo Group Limited Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
FR2796069B3 (fr) * 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
NZ540505A (en) * 2002-12-10 2007-02-23 Pfizer Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
AU2011255276B2 (en) * 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
ES2546492T3 (es) 2010-05-21 2015-09-24 Research Triangle Institute Derivados de 1-fenilmorfolina como análogos de hidroxibupropion para tratar drogodependencia
CN105949142B (zh) * 2016-05-21 2018-03-27 南华大学 具有抗抑郁活性的单一手性化合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997469A (en) * 1961-08-22 Preparation of substituted
GB851311A (en) * 1958-04-02 1960-10-12 Geigy Ag J R Morpholine compounds and their production
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
GB1336732A (en) * 1970-10-28 1973-11-07 Istituto Gentili Spa Pisa Diethanolamine derivatives
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
FR2517305B1 (fr) * 1981-12-01 1985-10-25 Lafon Labor Nouveaux derives de 2-phenyl-morpholine et leur utilisation en therapeutique
FR2553410B1 (fr) * 1983-10-14 1986-05-16 Lafon Labor Nouveaux derives de 2-tolyl-morpholine utiles en therapeutique
FR2553411B1 (fr) * 1983-10-14 1986-08-01 Lafon Labor Derives de 2-halogenophenyl-morpholine, procede de preparation et utilisation en therapeutique
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique
GB8417170D0 (en) * 1984-07-05 1984-08-08 Wellcome Found Heterocyclic pharmaceutical compounds
US4803200A (en) * 1987-10-02 1989-02-07 A. H. Robins Company, Incorporated Substituted dialkanolamines, sulfur analogs and condensed 1,4-oxazine derivatives thereof in viral disease treatment
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use

Also Published As

Publication number Publication date
FI934680L (fi) 1993-10-22
DE69227583D1 (de) 1998-12-17
GB9108629D0 (en) 1991-06-12
HUT70531A (en) 1995-10-30
FI934680A0 (fi) 1993-10-22
WO1992018489A1 (en) 1992-10-29
IE921260A1 (en) 1992-11-04
AU668863B2 (en) 1996-05-23
US5760224A (en) 1998-06-02
ATE173252T1 (de) 1998-11-15
EP0583271B1 (en) 1998-11-11
PT100415B (pt) 1999-08-31
CA2108967C (en) 2002-10-08
JPH06506675A (ja) 1994-07-28
HU219458B (hu) 2001-04-28
US5648347A (en) 1997-07-15
AU1575392A (en) 1992-11-17
EP0583271A1 (en) 1994-02-23
DK0583271T3 (da) 1999-07-26
HU9303000D0 (en) 1994-01-28
NZ242421A (en) 1994-10-26
CA2108967A1 (en) 1992-10-24
DE69227583T2 (de) 1999-04-01
ZA922910B (en) 1994-01-24
JP3130040B2 (ja) 2001-01-31
FI934680A7 (fi) 1993-10-22
ES2124256T3 (es) 1999-02-01

Similar Documents

Publication Publication Date Title
PT99794A (pt) Processo para a preparacao de novas piperazinas 1,4-dissubstituidas
ATE231519T1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
PL306590A1 (en) Substituted heterocyclic carboxylamides, method obtaining them and their application as therapeutic agents
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
UA44254C2 (uk) Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
PT100415A (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
IS3659A7 (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandi og kvalastillandi áhrif
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
HUP9902135A2 (hu) (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására
MY104521A (en) Treatment of depression.
ES2104938T3 (es) Metodo de inhibir la fibrosis.
ATE135217T1 (de) Pharmazeutische zusammensetzungen zur aids- behandlung
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
EP0769945A4 (en) METHOD FOR BONE HEALING AND BREAK REPAIR
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
RU94045839A (ru) Производные 3-(фенилалкиламиноалкилокси)-5-фенилпиразола, а также способ и промежуточные вещества для их получения, лекарственное средство, содержащее эти соединения
RU93058599A (ru) Новые диметиламинооксиалкандифосфоновые кислоты и их соли, способ их получения, содержащие их фармацевтические составы, применение

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930219

FG3A Patent granted, date of granting

Effective date: 19990521

MM3A Annulment or lapse

Effective date: 20041122